Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 17697895)

Published in Methods Enzymol on January 01, 2007

Authors

Yuliya Pylayeva1, Wenjun Guo, Filippo G Giancotti

Author Affiliations

1: Cell Biology Program, Memorial Sloan-Kettering Cancer Center, and Sloan-Kettering Division, Weill Graduate School of Medical Sciences, Cornell University, New York, New York, USA.

Articles by these authors

The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol (2008) 10.97

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29

Integrin signalling during tumour progression. Nat Rev Mol Cell Biol (2004) 6.53

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell (2011) 4.79

Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell (2006) 4.48

Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling. Mol Cell Biol (2009) 3.25

Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res (2007) 3.04

The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell (2012) 2.84

Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest (2009) 2.55

Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell (2010) 2.38

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res (2011) 1.96

Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell (2013) 1.86

Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol (2005) 1.86

Shedding light on Merlin's wizardry. Trends Cell Biol (2007) 1.85

Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell (2004) 1.83

Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol Cell Biol (2005) 1.44

Netrin-integrin signaling in epithelial morphogenesis, axon guidance and vascular patterning. Cell Cycle (2005) 1.42

Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus. EMBO Rep (2012) 1.30

Compartmentalization of integrin alpha6beta4 signaling in lipid rafts. J Cell Biol (2003) 1.23

The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis. Cell Cycle (2008) 1.09

Defective Rac-mediated proliferation and survival after targeted mutation of the beta1 integrin cytodomain. J Cell Biol (2002) 1.09

Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation. Mol Cell Biol (2002) 1.08

ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Neuro Oncol (2010) 1.04

β4 Integrin signaling induces expansion of prostate tumor progenitors. J Clin Invest (2013) 1.03

Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib. Mol Cancer Res (2010) 0.98

Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo. Exp Physiol (2009) 0.96

Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2013) 0.90

Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression. Sci Signal (2011) 0.89

p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow. Proc Natl Acad Sci U S A (2005) 0.89

Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A (2010) 0.84

Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008. Vaccine (2009) 0.83

ARK5 promotes glioma cell invasion, and its elevated expression is correlated with poor clinical outcome. Eur J Cancer (2012) 0.82

Tensin relief facilitates migration. Nat Cell Biol (2007) 0.81

Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1). Cell Cycle (2010) 0.81

Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer. Breast Cancer Res Treat (2015) 0.80

Development requires activation but not phosphorylation of beta1 integrins. Genes Dev (2006) 0.78

Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis. Arch Gynecol Obstet (2014) 0.76

Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy. Org Biomol Chem (2015) 0.76

Guido Tarone, Ph.D. (1951-2015). J Cell Sci (2015) 0.75

[Clinical research progress of mesenteric internal hernia after Roux-en-Y reconstruction]. Zhonghua Wei Chang Wai Ke Za Zhi (2017) 0.75

Melamine-tainted milk product-associated urinary stones in children. Pediatr Int (2011) 0.75

Synthesis and two-dimensional correlation infrared spectroscopy study of an organic-inorganic hybrid compound constructed by [Mo(5)P(2)O(23)] and Cu-imidazole components. Spectrochim Acta A Mol Biomol Spectrosc (2006) 0.75